Canadian Ebola Vaccine Begins Human Trials

News outlets report on the start of clinical trials testing a Canadian Ebola vaccine.

Agence France-Presse: Experimental Canadian Ebola vaccine starts human tests (10/13).
Globe and Mail: As vaccine trials begin, Canada set to review Ebola strategy (Wingrove, 10/14).
Reuters: Human testing begins on NewLink Genetics’ Ebola vaccine (Grover, 10/13).
Toronto Star: Canadian-made Ebola vaccine starting clinical trials in humans (Pelley, 10/13).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.